Intuitive Surgical price target lowered to $430 from $480 at Evercore ISI
Evercore ISI lowered the firm’s price target on Intuitive Surgical (ISRG) to $430 from $480 and keeps an In Line rating on the shares. The firm’s Q2 preview for MedTech,…
Fiscal Year: January - December
Intuitive Surgical, Inc. (ISRG), listed on the NASDAQ, has a market capitalization of $151.33B. As of Jul 08, 2026, the stock is trading at $427.30 per share@else an unavailable price , offering investors a clear view of its current market value. Intuitive Surgical, Inc. is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 51.93, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. Intuitive Surgical, Inc. also offers a dividend yield of N/A , making it an attractive option for income-focused investors who seek regular dividends.
DCF analysis data is not yet available for Intuitive Surgical, Inc. (ISRG). The fair value estimate will be displayed once sufficient analyst forecast data is collected.
The proprietary SS Score for Intuitive Surgical, Inc. is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for Intuitive Surgical, Inc., Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for Intuitive Surgical, Inc. is 53.39, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, Intuitive Surgical, Inc. (ISRG) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether Intuitive Surgical, Inc. (ISRG) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. It is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of Intuitive Surgical, Inc. (ISRG) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of Intuitive Surgical, Inc.. To access the full SS Score, consider upgrading your subscription.
Intuitive Surgical, Inc. is a significant player in the industry sector, with a market capitalization of $151.33B and a competitive P/E ratio of 51.93. Investors should compare these metrics with industry peers to gauge whether Intuitive Surgical, Inc. is outperforming or underperforming within its sector.
Evercore ISI lowered the firm’s price target on Intuitive Surgical (ISRG) to $430 from $480 and keeps an In Line rating on the shares. The firm’s Q2 preview for MedTech,…
In 2000, a “robot” mostly meant a caged arm bolted to a car line, repeating one welded seam. Most could not see, none could leave their cells unsupervised, and a full installation ran into six figures...
BofA analyst Travis Steed lowered the firm’s price target on Intuitive Surgical (ISRG) to $515 from $520 and keeps a Buy rating on the shares. Noting that the firm’s services…
Deutsche Bank lowered the firm’s price target on Intuitive Surgical (ISRG) to $366 from $440 and keeps a Sell rating on the shares.
Intuitive Surgical (ISRG) announced the promotion of Taylor Patton to chief commercial and marketing officer, effective July 1. Patton, formerly global senior VP of the company’s endoluminal business,...
Current Chief Commercial and Marketing Officer Henry Charlton to become SVP of Global Business Operations Current Chief Commercial and Marketing Officer Henry Charlton to become SVP of Global Business...
Goldman Sachs lowered the firm’s price target on Intuitive Surgical (ISRG) to $558 from $621 and keeps a Buy rating on the shares. MedTech has experienced one of its weakest…
Latest innovations include enhanced telecollaboration capabilities, extended uses for Force Feedback technology, and advancements in product and instrument reliability and security Latest innovations ...
BofA lowered the firm’s price target on Intuitive Surgical (ISRG) to $520 from $650 and keeps a Buy rating on the shares. After having hosted 34 medtech companies last week…
Healthcare is regaining momentum as innovation—especially AI‑driven drug discovery—creates new growth opportunities, according to Shivani Vohra. She points to obesity treatments from Eli Lilly (LLY) a...
The FDA is aware that Intuitive Surgical (ISRG) has issued a letter to affected customers recommending all 8mm SureForm 30 gray reloads for curved-tip staplers be removed from where they…
Intuitive Surgical ($ISRG) remains an attractive long-term story following another strong quarter. The Q1 results released on April 21 reinforced the durability of its growth model. The leader in mini...
The key takeaway from Intuitive Surgical's (ISRG) Q1 2026 results is the implementation of a fundamental “Platform Refresh Wall.” In addition to the $2.50 EPS exceeding expectations and a revenue grow...
Barclays lowered the firm’s price target on Intuitive Surgical (ISRG) to $651 from $712 and keeps an Overweight rating on the shares post the Q1 report. The company reported a…
Baird raised the firm’s price target on Intuitive Surgical (ISRG) to $610 from $575 and keeps an Outperform rating on the shares. The firm updated its model following beat and…
Piper Sandler analyst Adam Maeder lowered the firm’s price target on Intuitive Surgical (ISRG) to $580 from $620 and keeps an Overweight rating on the shares. The firm notes the…
Intuitive Surgical on Tuesday beat Wall Street estimates for first-quarter profit and revenue, as the firm rode the wave of robust demand for its minimally invasive surgical robots used in complex m...
SUNNYVALE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today...
BOCA RATON, Fla.--(BUSINESS WIRE)---- $ISRG #FDAcleared--SurGenTec, LLC, a leader in innovative spine and orthopedic technologies, today announced that the U.S. Food and Drug Administration (FDA) has ...
Holiday shoppers look for “For Sale” signs, while those shopping during Thanksgiving seek out bargains. In retail, a reduction in price is an invitation to act.
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.